USF Health
USF
Search
News
Education
Research
Patient Care
USF Health
>
Morsani College of Medicine
>
Cardiovascular Sciences
Cardiovascular Sciences
Print Friendly
Home
About
Physicians
Patient Info
Patient Information Homepage
Make an Appointment
Symptom Checker
Common Heart Conditions
Procedures
Fellowships
Fellowship Homepage
Current Fellows
Alumni
Research
News
Contact
Email:
mguglin@health.usf.edu
Phone:
(813) 259-0992
Request this doctor
— appointment —
Maya Guglin,
MD PHD
Associate Professor, College Of Medicine Cardiology
College Of Medicine Cardiology
Education
PHD
, Rheumatology, Volgograd Medical School, 1990
MD
, Medicine - Cardiology, Volgograd Medical School, 1984
Research Interests
Maya Guglin, MD, PhD, is an Associate Professor of Medicine and Director of Heart Failure in University of South Florida. She also runs the adult congenital heart disease program (together with Dr. Dadlani) and cardiomyopathy clinic seeing patients with genetic and familial cardiomyopathy, peripartum cardiomyopathy, cardiac amyloidosis, cardiac sarcoidosis, chemotherapy induced cardiomyopathy, right ventricular failure.
Native of Russia, she graduated from Volgograd medical school in 1984 and worked as a Cardiology attending in the CCU for several years before coming to US in 1997. Her American training took place in Case Western Reserve University (residency) and UMDNJ (fellowship). She joined USF in 2006. As a USF faculty she practices not only in University clinics but also at Tampa General Hospital and Moffitt Cancer Institute.
Dr. Guglin’s clinical and research interests include heart failure, chemotherapy-induced cardiomyopathy, adult congenital heart diseases, pulmonary hypertension, unusual cardiomyopathies, echocardiography, cardiac transplantation and left ventricular assist devices. Dr. Guglin authored and co-authored about 50 articles in peer review journals. She regularly presents at the scientific sessions of the American Heart Association, American College of Cardiology, Heart Failure Society of America, etc. She is a member of the ACC Heart Failure and Transplant committee. Her most important contributions are:
• Key role of diuretics in treatment of heart failure.
• Concept of congestion as a leading factor in the pathogenesis of heart failure
• Ultrafiltration in diuretic resistant heart failure
• Intravenous nitroglycerin, including high doses, in refractory heart failure including cardiogenic shock
• Similarity of neurogenic stunned myocardium and takotsubo (stress induced) cardiomyopathy
• Congestion as a pivotal factor of cardiorenal syndrome
• Connection of atrial fibrillation and heart failure
• Trastuzumab-induced cardiomyopathy
Specialties
Cardiology
Selected Publications
Law, C.Glover, C.Benson, K.Guglin, M.
Extremely high brain natriuretic peptide does not reflect the severity of heart failure.
Congestive heart failure (Greenwich, Conn.)
. 16 (5) : 221-5,
http://www.ncbi.nlm.nih.gov/pubmed/20887619
Maradia, K.Guglin, M.
Pharmacologic prevention of anthracycline-induced cardiomyopathy.
Cardiology in review
. 17 (5) : 243-52,
http://www.ncbi.nlm.nih.gov/pubmed/19690476
Guglin, M.
Reappraisal of the role of diuretics in heart failure.
Cardiology in review
. 17 (2) : 56-9,
http://www.ncbi.nlm.nih.gov/pubmed/19367146
Moses, H.Yarnoz, MJ.Guglin, M.
Cardiac manifestations of Fabry's disease: a story of mother and son.
Congestive heart failure (Greenwich, Conn.)
. 15 (2) : 93-5,
http://www.ncbi.nlm.nih.gov/pubmed/19379456
Dix, SK.Rosner, GF.Nayar, M.Harris, JJ.Guglin, ME.Winterfield, JR.Xiong, Z.Mudge, GH.
Intractable cardiac arrest due to lidocaine toxicity successfully resuscitated with lipid emulsion.
Critical care medicine
. 2011.
http://www.ncbi.nlm.nih.gov/pubmed/21263316
Guglin, M.Rivero, A.Matar, F.Garcia, M.
Renal dysfunction in heart failure is due to congestion but not low output.
Clinical cardiology
. 34 (2) : 113-6, 2011.
http://www.ncbi.nlm.nih.gov/pubmed/21298655
Patel, V.Fountain, A.Guglin, M.Nanda, NC.
Three-dimensional transthoracic echocardiography in identification of aorto-right atrial fistula and aorto-right ventricular fistulas.
Echocardiography (Mount Kisco, N.Y.)
. 27 (9) : E105-8, 2010.
http://www.ncbi.nlm.nih.gov/pubmed/20584055
Guglin, M.Kristof-Kuteyeva, O.Novotorova, I.Pratap, P.
Aldosterone Antagonists in Heart Failure.
Journal of cardiovascular pharmacology and therapeutics
. 2010.
http://www.ncbi.nlm.nih.gov/pubmed/21160084
Guglin, M.Chen, R.Curtis, AB.
Sinus rhythm is associated with fewer heart failure symptoms: insights from the AFFIRM trial.
Heart rhythm : the official journal of the Heart Rhythm Society
. 7 (5) : 596-601, 2010.
http://www.ncbi.nlm.nih.gov/pubmed/20159046
Kolli, S.Douglas, J.Doumit, E.Guglin, M.
Cardiomyopathy and calciphylaxis in a patient with normal renal function: a case report.
Congestive heart failure (Greenwich, Conn.)
. 16 (2) : 71-2, 2010.
http://www.ncbi.nlm.nih.gov/pubmed/20412472
Novitzky, D.Guglin, M.
Chylopericardium presenting with tamponade and cardiogenic shock.
Journal of cardiac surgery
. 25 (5) : 522-4, 2010.
http://www.ncbi.nlm.nih.gov/pubmed/20487105
Guglin, M.Khan, H.
Pulmonary hypertension in heart failure.
Journal of cardiac failure
. 16 (6) : 461-74, 2010.
http://www.ncbi.nlm.nih.gov/pubmed/20610227
Mateja, C.Mishkin, J.George, M.Chheda, H.Guglin, M.
False positive stress-test in a patient with pericardial effusion.
International journal of cardiology
. 137 (2) : e33-4, 2009.
http://www.ncbi.nlm.nih.gov/pubmed/18768227
Ahlgrim, C.Guglin, M.
Anabolics and cardiomyopathy in a bodybuilder: case report and literature review.
Journal of cardiac failure
. 15 (6) : 496-500, 2009.
http://www.ncbi.nlm.nih.gov/pubmed/19643360
Guglin, M.Hartlage, G.Reynolds, C.Chen, R.Patel, V.
Trastuzumab-induced cardiomyopathy: not as benign as it looks? A retrospective study.
Journal of cardiac failure
. 15 (8) : 651-7, 2009.
http://www.ncbi.nlm.nih.gov/pubmed/19786253
Guglin, M.Aljayeh, M.Saiyad, S.Ali, R.Curtis, AB.
Introducing a new entity: chemotherapy-induced arrhythmia.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
. 11 (12) : 1579-86, 2009.
http://www.ncbi.nlm.nih.gov/pubmed/19801562
Guglin, M.Postler, G.
High dose nitroglycerin treatment in a patient with cardiac arrest: a case report.
Journal of medical case reports
. 3 : 8782, 2009.
http://www.ncbi.nlm.nih.gov/pubmed/19830240
Novitzky, D.Guglin, M.Sheffield, C.
Cardiac autotransplantation for removal of left atrial hemangioma and a review of the literature.
The heart surgery forum
. 12 (5) : E279-84, 2009.
http://www.ncbi.nlm.nih.gov/pubmed/19833595
Guglin, M.Cutro, R.Mishkin, JD.
Trastuzumab-induced cardiomyopathy.
Journal of cardiac failure
. 14 (5) : 437-44, 2008.
http://www.ncbi.nlm.nih.gov/pubmed/18514938
Steiner, J.Guglin, M.
BNP or NTproBNP? A clinician's perspective.
International journal of cardiology
. 129 (1) : 5-14, 2008.
http://www.ncbi.nlm.nih.gov/pubmed/18378336
Guglin, M.Garcia, M.Yarnoz, MJ.Curtis, AB.
Non-antiarrhythmic medications for atrial fibrillation: from bench to clinical practice.
Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing
. 22 (2) : 119-28, 2008.
http://www.ncbi.nlm.nih.gov/pubmed/18317915